journal article·2026-03Open access

Staphylococcus aureus and Escherichia coli inactivation through mercaptophenylboronic acid-functionalized fluorinated porphyrin

Daiane N. Maronde, Cátia Vieira, José E. Rodríguez-Borges, Adelaide Almeida, Leandro M.O. Lourenço

Dyes and Pigments· Volume 246

Abstract

Photodynamic inactivation (PDI) represents an effective strategy to combat resistant pathogens, emerging as a potential approach against Gram-positive and Gram-negative bacteria. Here, we report for the first time the synthesis, characterization, and photophysical properties of novel free-base fluorinated porphyrin tetra-substituted with 4-mercaptophenylboronic acid units (H 2 Por 1 ). The PDI of H 2 Por 1 was assessed against methicillin resistant Staphylococcus aureus (MRSA) and Escherichia coli using two photosensitizer (PS) concentrations (5.0 and 10.0 μM) under white light irradiation at 100 mW cm −2 , with exposure times of up to 60 min (total light dose of 360 J cm −2 ). For MRSA, H 2 Por 1 alone at 5–10 μM promoted bacterial inactivation in 45–60 min (270–360 J cm −2 ) of irradiation, highlighting the PS concentration and irradiation time dependence. When combined with KI, H 2 Por 1 exhibited pronounced synergistic effects, leading to a viability reduction >8 Log CFU/mL in MRSA in ≤5 min (30 J cm −2 ). For E. coli , H 2 Por 1 alone, even at 10 μM, did not inactivate the bacterium under the tested conditions. The addition of KI enabled effective inactivation of E. coli within ≤5 min of irradiation, demonstrating a strong combined effect between the PS and KI > 8 Log CFU/mL. These findings reinforce the potential of H 2 Por 1 as a versatile antimicrobial agent, particularly when combined with KI, for the photodynamic treatment of infections caused by Gram-positive and Gram-negative bacteria. The H 2 Por 1 effective performance even with low PS concentrations and low irradiation levels represents a significant advantage for future clinical applications in antimicrobial photodynamic therapy. • Photoinactivation (PDI) of S. aureus and E. coli bacteria using a porphyrin dye (H 2 Por 1 ). • H 2 Por 1 generates singlet oxygen under white light irradiation. • Potassium iodide (KI) enhances PDI efficiency, reducing time for bacterial inactivation. • H 2 Por 1 achieved a bacterial viability reduction >8 Log CFU/mL in ≤5 min.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Advanced Photocatalysis Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (63)

Show source-provided references
1. A critical review on the potential of inactivated bacteria in counteracting human pathogens10.1007/s00284-025-04282-2 ↗
2. Photocatalytic antimicrobials: principles, design strategies, and applications10.1021/acs.chemrev.3c00326 ↗
3. Overview of cationic phthalocyanines for effective photoinactivation of pathogenic microorganisms10.1016/j.jphotochemrev.2021.100422 ↗
4. Antibiotic resistance – the faceless threat10.3233/JRS-2005-347 ↗
5. Threats of antibiotic resistance: an obliged reappraisal10.1007/s10123-021-00184-y ↗
6. Photodynamic inactivation mediated by endogenous porphyrins of Corynebacterium diphtheriae in planktonic and biofilm forms10.1021/acsomega.4c09308 ↗
7. Photoinactivation of mycobacteria to combat infection diseases: current state and perspectives10.1007/s00253-021-11349-0 ↗
8. Versatile thiopyridyl/pyridinone porphyrins combined with potassium iodide and thiopyridinium/methoxypyridinium porphyrins on E. coli photoinactivation10.1016/j.dyepig.2020.108476 ↗
9. Advancements in photodynamic inactivation: a comprehensive review of photosensitizers, mechanisms, and applications in food area10.1111/1541-4337.70127 ↗
10. Inverted methoxypyridinium phthalocyanines for PDI of pathogenic bacteria10.1039/c5pp00145e ↗
11. Conjugated photosensitizers for imaging and PDT in cancer research10.1021/acs.jmedchem.0c00047 ↗
12. Bacterial photodynamic inactivation: eradication of Staphylococcus aureus and Escherichia coli mediated by pyridinium-pyrazolyl Zinc(II) phthalocyanines10.1021/acsabm.4c01368 ↗
13. Complete photodynamic inactivation of Pseudomonas aeruginosa biofilm with use of potassium iodide and its comparison with enzymatic pretreatment
14. Factors determining the susceptibility of bacteria to antibacterial photodynamic inactivation10.3389/fmed.2021.642609 ↗
15. Antibacterial photodynamic therapy: overview of a promising approach to fight antibiotic-resistant bacterial infections
16. Garapati C, Boddu SHS, Jacob S, Ranch KM, Patel C, Babu RJ, et al. Photodynamic therapy: a special emphasis on nanocarrier-mediated delivery of photosensitizers in antimicrobial therapy. Arab J Chem.16:104583..10.1016/j.arabjc.2023.104583 ↗
17. Chapter three - photodynamic inactivation (PDI) as a promising alternative to current pharmaceuticals for the treatment of resistant microorganisms
18. Potentiation of antimicrobial photodynamic inactivation by inorganic salts10.1080/14787210.2017.1397512 ↗
19. In vitro potentiation of antimicrobial photodynamic inactivation by addition of potassium iodide
20. Advances in aPDT based on the combination of a porphyrinic formulation with potassium iodide: effectiveness on bacteria and fungi planktonic/biofilm forms and viruses10.1142/S1088424619500408 ↗
21. Potentiation by potassium iodide reveals that the anionic porphyrin TPPS4 is a surprisingly effective photosensitizer for antimicrobial photodynamic inactivation10.1016/j.jphotobiol.2017.10.036 ↗
22. Unveiling the potent antimicrobial photodynamic therapy in Gram-positive and Gram-negative bacteria – water remediation with monocharged chlorins10.1016/j.chemosphere.2024.143593 ↗
23. Almeida Adelaide an insight into the potentiation effect of potassium iodide on aPDT efficacy
24. Effective light-driven inactivation of Escherichia coli with ammonium porphyrin-based photosensitizers10.1016/j.jddst.2025.107323 ↗
25. Cationic photosensitizers and potassium iodide: an innovative approach for enhanced photodynamic inactivation of pathogenic bacteria in aquaculture
26. Global prevalence of Staphylococcus aureus in food products and its relationship with the occurrence and development of diabetes mellitus10.1002/med4.6 ↗
27. Spread of Staphylococcus aureus in hospitals: causes and prevention10.1080/003655400459478 ↗
28. Shiga (Vero)-toxin producing Escherichia coli isolated from the hospital foods; virulence factors, o-serogroups and antimicrobial resistance properties10.1186/s13756-016-0163-y ↗
29. Food-borne origins of Escherichia coli causing extraintestinal infections10.1093/cid/cis502 ↗
30. Treatment of Staphylococcus aureus infections
31. Staphylococcus aureus, an important pathogen of public health and economic importance: a comprehensive review
32. Escherichia coli causing neonatal meningitis during 2001–2020: a study in Eastern China10.2147/IJGM.S317299 ↗
33. Enteroaggregative escherichia coli: frequent, yet underdiagnosed pathotype among E. coli O111 strains isolated from children with gastrointestinal disorders in the Czech Republic10.1016/j.ijmm.2024.151628 ↗
34. Mortality in Escherichia coli bloodstream infections: a multinational population-based cohort study10.1186/s12879-021-06326-x ↗
35. Photodynamic inactivation of Escherichia coli and Staphylococcus aureus by cationic diketopyrrolopyrroles
36. β-Pyrrole functionalized porphyrins: synthesis, electronic properties, and applications in sensing and DSSC
37. Recent advances in subporphyrins and triphyrin analogues: contracted porphyrins comprising three pyrrole rings10.1021/acs.chemrev.6b00403 ↗
38. Bactericidal efficiency of porphyrin systems10.1142/S1088424621500358 ↗
39. Photodynamic inactivation of bacteria: finding the effective targets10.4155/fmc.15.59 ↗
40. Potential applications of porphyrins in photodynamic inactivation beyond the medical scope10.1016/j.jphotochemrev.2014.09.003 ↗
41. Recent photosensitizer developments, delivery strategies and combination-based approaches for photodynamic therapy10.1111/php.13749 ↗
42. Boronic acid functionalized photosensitizers: a strategy to target the surface of bacteria and implement active agents in polymer coatings10.1002/anie.201703398 ↗
43. Boronic acid-assisted detection of bacterial pathogens: applications and perspectives10.1016/j.ccr.2024.216082 ↗
44. A dual-targeted platform based on graphene for synergistic chemo-photothermal therapy against multidrug-resistant Gram-negative bacteria and their biofilms10.1016/j.cej.2020.124595 ↗
45. Direct discrimination of cell surface glycosylation signatures using a single pH-responsive boronic acid-functionalized polymer10.1039/D2SC02116A ↗
46. Biological and medicinal applications of boronic acids10.1002/3527606548.ch13 ↗
47. Boronic acid-decorated multivariate photosensitive metal–organic frameworks for combating multi-drug-resistant bacteria10.1021/acsnano.1c11613 ↗
48. Kadish KMS · 2010
49. Linear free energy relationship analysis of solvent effect on singlet oxygen reactions with mono and disubstituted anthracene derivatives10.1016/j.jphotochem.2009.05.012 ↗
50. Photodynamic inactivation of recombinant bioluminescent Escherichia coli by cationic porphyrins under artificial and solar irradiation10.1007/s10295-008-0446-2 ↗
51. Reexamining the heavy-atom-effect: the universal heavy-atom-induced fluorescence enhancement principle for through-space conjugated AIEgens10.1016/j.cej.2022.139030 ↗
52. External heavy-atom effect on fluorescence kinetics10.1039/b002307h ↗
53. The fluorine effect: photophysical properties of borondipyrromethene (bodipy) dyes appended at the meso position with fluorinated aryl groups10.1039/c2ra20219k ↗
54. Comprehensive review of photophysical parameters (ε, Φf, τs) of tetraphenylporphyrin (H2TPP) and zinc tetraphenylporphyrin (ZnTPP) – critical benchmark molecules in photochemistry and photosynthesis10.1016/j.jphotochemrev.2020.100401 ↗
55. New photosensitizers for photodynamic therapy10.1042/BJ20150942 ↗
56. Photosensitized oxidation of 9,10-dimethylanthracene with singlet oxygen by using a safranin O/silica composite under visible light10.1039/c4pp00261j ↗
57. Photodynamic therapy based on porphyrin-based metal–organic frameworks10.1039/D2TB02789E ↗
58. Singlet oxygen in photodynamic therapy10.3390/ph17101274 ↗
59. Uptake pathways of anionic and cationic photosensitizers into bacteria10.1039/b809624d ↗
60. A2B2-type porphyrins enhanced by N-donor units: synthesis optimization and photodynamic efficiency towards S. aureus10.1016/j.bioorg.2025.108607 ↗
61. The chemical reduction of molecular iodine added to seawater, modelled as a system of linked first-order reactions10.1016/0304-4203(93)90009-D ↗
62. Phenylboronic acid-functionalized BSA@CuS@PpIX nanoparticles for enhanced antibacterial photodynamic/photothermal therapy
63. Instructions to authors